- Heart Failure
- Metabolic Cardiology
- Cardio-Oncology
- +۳ مورد دیگر
Stephan von Haehling is DZHK Professor of Metabolic Cardiology at the University of Göttingen's Faculty of Medicine and Heart Center Göttingen. He serves as spokesperson for the German Society of Cardiology's Heart Failure Working Group and deputy editor of ESC Heart Failure , focusing on clinically relevant heart failure and cardio-oncology research. His primary research examines comorbidities in heart failure, particularly sarcopenia (affecting over 20% of patients) and bone metabolism deterioration. His team demonstrated sarcopenia's role as an independent mortality predictor, leading to its inclusion in European Society of Cardiology guidelines. In cardio-oncology, they investigate cancer-induced cardiovascular changes that impair physical resilience and quality of life, identifying biomarkers like osteoprotegerin and kynurenine for early prediction. Recent publications (2020-2023) emphasize heart failure management during the COVID-19 pandemic, cardio-oncology quality-of-life metrics, bone health in heart failure, and diagnostic biomarkers for acute heart failure. His work combines clinical trials, retrospective analyses, and biomarker validation, significantly influencing European treatment guidelines. Prof. von Haehling leads a research team at Göttingen's Heart Center, conducting translational studies on metabolic cardiology with international collaborations through the German Centre for Cardiovascular Research (DZHK).